Landis+Gyr Announces First Half FY 2021 Financial Results
/PRNewswire/ -- Landis+Gyr (SIX: LAND) today announced unaudited financial results for the first half of financial year 2021 (April 1st - September 30th, 2021)....
Stay updated with breaking news from Adjusted Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Landis+Gyr (SIX: LAND) today announced unaudited financial results for the first half of financial year 2021 (April 1st - September 30th, 2021)....
Aquestive Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update Libervant™ (diazepam) Buccal Film New Drug Application (NDA) resubmission expected end of second quarter 2021 Epinephrine program and development strategy to be highlighted at a virtual investor event to be held at 9:00 a.m. ET on March 25, 2021 Entered U.S. licensing and supply agreement for Riluzole Oral Film for treatment of ALS with Mitsubishi Tanabe Pharma America Sympazan ® (clobazam) continues to meet key performance metrics Management to host conference call and webcast a...